Authors >
Charles Bankhead
Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. His career spans more than 30 years, including a decade with Medical World News, a leading medical trade magazine of its time. He had a long and successful freelance career before joining 番茄社区 in 2007. Charles graduated with honors from Texas Tech University, receiving a BA in journalism, and completed a master's degree in mass communication, with specialization in health communication, also at Texas Tech.
Connect:
Latest from Charles Bankhead
OncoBriefs: Zalutumumab Misses Mark in H&N Cancer
SCOTTSDALE, Ariz. -- Chemoradiation plus the targeted agent zalutumumab failed to improve disease control or survival in patients with squamous cell head and neck cancer, a finding that leads this roundup of news from the Multidisciplinary Head and Neck Cancer Symposium.
Feb 22, 2014
OncoBlog: Driving the CAR to a Cancer Cure?
Is immunotherapy with chimeric antigen receptor (CAR)-directed T cells the "next big thing" in oncology? Presentations and discussion at a recent conference suggest the technology has considerable promise -- but will it qualify as a breakthrough? OncoBlog is a blog by the 番茄社区
Medical Today staff for readers with an interest in oncology. This post comes from Charles Bankhead.
Dec 19, 2013
10 Questions: John P. Erwin, MD
What's the biggest barrier to practicing medicine today? That's just the first of 10 questions the 番茄社区 staff is asking leading clinicians and researchers to get their personal views on their chosen profession. In this series we share their uncensored responses. Here, answers from John P. Erwin, MD, of Scott & White Healthcare in Temple, Texas.
Dec 04, 2013